Capsule endoscopy: High negative predictive value in the long term despite a low diagnostic yield in patients with suspected crohn’s disease

United European Gastroenterology Journal

Volumn 1, Issue 6, 2013, Pages 461-466

  Hall, Barry ^a   Holleran, Grainne ^a   Costigan, Danielle ^b   McNamara, Deirdre ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Capsule endoscopy; Negative predictive value; Suspected Crohn s disease

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; C REACTIVE PROTEIN; MESALAZINE;

ADULT; AGED; ARTICLE; CAPSULE ENDOSCOPY; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DIAGNOSTIC VALUE; ENTERITIS; ESOPHAGUS STENOSIS; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL;

EID: 85006217679     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640613508551     Document Type: Article

References (25)

1. Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-1794.
2. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications. Gut 2006; 55: 749-753.
3. Gong F, Swain P and Mills T. Wireless endoscopy. Gastrointest Endosc 2000; 51: 725-729.
4. Swain P, Iddan G, Meron G, et al, Wireless capsule endoscopy of the small-bowel: development, testing and first human trials. In: Biomonitoring and Endoscopy Technologies, vol. 4158 of Proceedings of SPIE. Amsterdam: The Netherlands, 2000. pp. 19-23.
5. Mergener K. Update on the use of capsule endoscopy. Gastroenterol Hepatol (NY) 2008; 4: 107-110.
6. Triester SL, Leighton JA, Leontiadis GI, et al. A metaanalysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with obscure gastrointestinal bleeding. Am J Gastroenterol 2005; 100: 2407-2418.
7. Dionisio PM, Gurudu SR, Leighton JA, et al. Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small-bowel Crohn’s disease: a meta-analysis. Am J Gastroenterol 2010; 105: 1240-1248.
8. Sidhu R, Sanders DS, Morris AJ, et al. Guidelines on small bowel enteroscopy and capsule endoscopy in adults. Gut 2008; 57: 125-136.
9. Long MD, Barnes E, Isaacs K, et al. Impact of capsule endoscopy on management of inflammatory bowel disease: A single tertiary care center experience. Inflamm Bowel Dis 2011; 17: 1855-1862.
10. Pimentel M, Chang M, Chow EJ, et al. Identification of a prodromal period in Crohn’s disease but not ulcerative colitis. Am J Gastroenterol 2000; 95: 3458-3462.
11. Timmer A, Breuer-Katschinksi B and Goeball H. Time trends in the incidence and disease location of Crohn’s disease 1980-1995: A prospective analysis in an urban population in Germany. Inflamm Bowel Dis 1999; 5: 79-84.
12. Hebuterne X, Lemann M and Bouhnik Y. Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn’s disease following treatment with certolizumab pegol. Gut 2013; 62: 201-208.
13. de Melo SW Jr and Di Palma JA. The role of capsule endoscopy in evaluating inflammatory bowel disease. Gastroenterol Clin North Am 2012; 41: 315-323.
14. Mow WS, Lo SK, Targan SR, et al. Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol 2004; 2: 31-40.
15. Kalla R, McAlindon ME, Drew K, et al. Clinical utility of capsule endoscopy in patients with Crohn’s disease and inflammatory bowel disease unclassified. Eur J Gastroenterol Hepatol 2013; 25: 706-713.
16. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011; 60: 571-607.
17. Schnitzler F, Fidder H, Ferrante M, et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn’s disease. Inflamm Bowel Dis 2009; 15: 1295-1301.
18. Höög CM, Bark L-A, Arkani J, et al. Capsule retentions and incomplete capsule endoscopy examinations: An analysis of 2300 examinations. Gastroenterol Res Pract 2012; 2012: 518718.
19. Cheifetz AS, Kornbluth AA, Legnani P, et al. The risk of retention of the capsule endoscope in patients with known or suspected Crohn’s disease. Am J Gastroenterol 2006; 101: 2218-2222.
20. Liao Z, Gao R, Xu C, et al. Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review. Gastrointest Endosc 2010; 71: 280-286.
21. Niv Y, Ilani S, Levi Z, et al. Validation of the Capsule Endoscopy Crohn’s Disease Activity Index (CECDAI or Niv score): a multicenter prospective study. Endoscopy 2012; 44: 21-26.
22. Rosa B, Moreira MJ, Rebelo A, et al. Lewis score: A useful clinical tool for patients with suspected Crohn’s disease submitted to capsule endoscopy. J Crohn’s Colitis 2012; 6: 692-697.
23. Tukey M, Pleskow D, Legnani P, et al. The utility of capsule endoscopy in patients with suspected Crohn’s disease. Am J Gastronterol 2009; 104: 2734-2739.
24. Vermeire S, van Assche G and Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 2006; 55: 426-431.
25. Moscandrew ME and Loftus EV Jr. Diagnostic advances in inflammatory bowel disease (imaging and laboratory). Curr Gastroenterol Rep 2009; 11: 488-495.